Consorta Wound Closure Agreements Expected to Save Millions
Three new suture product agreements recently announced by Consorta are expected to deliver significant savings to Catholic Health Initiatives and its market-based organizations. The agreements with United States Surgical/Davis & Geck for suture products; with United States Surgical AutoSuture for stapling and endomechanical products; and with WECK, Inc., for manual ligation products will deliver system-wide savings of $23 to $34 million during the next five years.
The agreements, which replace prior Consorta agreements with Ethicon, are the result of extensive clinical product evaluations performed by surgeons and operating room staff in facilities throughout the Consorta membership, including five Catholic Health Initiatives hospitals that participated in the initial trials. "This is a great example of involving clinicians in the contracting process," said Mears. "Clinical acceptability was the top consideration in making these contract awards."
By the end of October, 100 percent of Catholic Health Initiatives
market-based organizations had signed letters of commitment to trial the new products, which will result in maximum rebates from the manufacturers as facilities convert to the new agreements.